Bio-Rad Norway
Life science research and clinical diagnostic products for researchers, laboratories and healthcare providers
Highlights
- New on EvolcAdded 2026-10-29
About Bio-Rad Norway
Bio-Rad develops and manufactures instruments, reagents, quality control solutions and data tools for life science research and clinical diagnostics. Its products cover areas including PCR, blood typing, immunoassays and chromatography.
The Norwegian legal entity, BIO-RAD NORWAY AS, is based in Oslo and was founded in 2017. The global company serves life science research and clinical diagnostic markets.
Product: Instruments, reagents, quality control solutions and data tools for life science research and clinical diagnostics.
Public tenders won
14 tenders won since 1 Jan 2024 from 10 public buyers in Finland, Norway, worth 71.1M NOK + €30.6M as awarded. From EU award notices (TED) that name Bio-Rad Norway by its registry number.
- 28 Sep 2026 Folkehelseinstituttet · 26/02086 Plate based qPCR machines for FHI - New notice · 4.0M NOK notice
- 12 Aug 2026 NordLab hyvinvointiyhtymä · Verikeskusanalytiikan automaatiojärjestelmät Nordlab verikeskuksiin · €2.3M notice
- 13 May 2026 UiT Norges arktiske universitet · Framework agreement chemicals · 50.0M NOK notice
- 30 Apr 2026 STATSBYGG · 1105601 UiO Life Sciences user equipment. K931.03 Various chromatography · 8.0M NOK notice
- 18 Feb 2026 HUS Group · TaqMan Assays for droplet digital PCR + controls and cDNA synthesis Kit · €691k notice
- 26 Jan 2026 Itä-Suomen yliopisto · Laboratoriotarvikkeiden ja -kemikaalien puitejärjestely · €20.0M notice
Jobs at Bio-Rad Norway
More biotech & pharma companies
Biobank
Biobanking and genetic testing services for animal breeders and breeding organisationsNew on EvolcBionér
Soil and compost analysis services for farmers, compost producers and other land usersNew on EvolcBlue Analytics
Diagnostic and genomic lab analyses for fish health and aquaculture producers, run in Bergen, NorwayNew on EvolcCalluna Pharma
Clinical-stage biotech developing antibodies against fibrosis and inflammation, with lead asset CAL101 for IPFYoung companyNew on EvolcCalpro
Calprotectin diagnostic tests and monitoring tools for laboratories, clinicians and patientsNew on EvolcCardinor
Develops secretoneurin blood assays that give prognostic information for cardiovascular disease, for laboratories and researchersNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Drupal
- jQuery
- nginx